Inspire Medical Systems (NYSE:INSP), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) ...

This was the stock's second consecutive day of gains.

Reports Q4 revenue $239.72M, consensus $237.41M. “We are thrilled with our strong performance in the fourth quarter, growing revenue 25% ...

Elevance Health has inked a deal with Verily to acquire its stop-loss insurance unit, Granular Insurance Company, a ...

Incyte says 2025 is expected to be a year of defining catalysts with four launches, four pivotal study readouts, at least ...